Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients

INTRODUCTION AND OBJECTIVES: Transcatheter chemoembolization (TACE) is the recommended therapy for intermediate stage hepatocellular carcinoma patients. Unfortunately, one of the main reasons for its failure is the emergence of multidrug resistance (MDR). Therefore, this study explored the possibili...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelaziz, Heba E., El-Guendy, Nadia, Radwan, Enas M, Sharawi, Sabry K, El Houseini, Motawa E, Abdel-Wahab, Abdel-Hady A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971467/
https://www.ncbi.nlm.nih.gov/pubmed/36579994
http://dx.doi.org/10.31557/APJCP.2022.23.12.4125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971467/
https://www.ncbi.nlm.nih.gov/pubmed/36579994
http://dx.doi.org/10.31557/APJCP.2022.23.12.4125

Ejemplares similares